published Jun 4th 2017, 7:15 pm, by Tracy Alloway and Joe Weisenthal (Bloomberg) — Every week, hosts Joe Weisenthal and Tracy Alloway take you on a not-so-random walk through hot topics in markets, finance and economics. For the past few years, everyone in markets has been talking about nothing. Market moves have been subdued

©2016 Bloomberg News O0GH0E6S9729 (Bloomberg) — Editas Medicine Inc., the drugmaker whose backers include Bill Gates and Google Ventures, filed to become the first publicly traded company to specialize in a new technology to edit flaws in genes. The company, which uses a gene-editing technique called Crispr, filed Monday for